CoChat

Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs

Open access
Weinstein, Edward A., Yano, Takahiro, Li, Lin-Sheng, Avarbock, David, Avarbock, Andrew, Helm, Douglas, McColm, Andrew A., Duncan, Ken, Lonsdale, John T., Rubin, Harvey · 2005 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Mycobacterium tuberculosis (Mtb) is an obligate aerobe that is capable of long-term persistence under conditions of low oxygen tension. Analysis of the Mtb genome predicts the existence of a branched aerobic respiratory chain terminating in a cytochrome bd system and a cytochrome aa 3 system. Both chains can be initiated with type II NADH:menaquinone oxidoreductase. We present a detailed biochemical characterization of the aerobic respiratory chains from Mtb and show that phenothiazine analogs specifically inhibit NADH:menaquinone oxidoreductase activity. The emergence of drug-resistant strains of Mtb has prompted a search for antimycobacterial agents. Several phenothiazines analogs are highly tuberculocidal in vitro , suppress Mtb growth in a mouse model of acute infection, and represent lead compounds that may give rise to a class of selective antibiotics.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0500469102

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Research works printed but not linked: 3

  1. Ratnakar, P. & Murthy, P. S. (1992) FEMS Microbiol. Lett. 76, 73–76.1427006
  2. Molnar, J., Beladi, I. & Földes, I. (1977) Zentralbl. Bakteriol. Mikrobiol. Hyg. Ser. A 239, 521–526.
  3. Kristiansen, J. E. & Vergmann, B. (1986) Acta Pathol. Microbiol. Scand. Sec. B. 94, 393–398.

Cited by

See all 289

Metadata

Authors
Weinstein, E. A., Yano, T., Li, L.-S., Avarbock, D., Avarbock, A., Helm, D., McColm, A. A., Duncan, K., Lonsdale, J. T., & Rubin, H.
Affiliations
University of Pennsylvania (US)
Corresponding author
Rubin, Harvey
Venue
Proceedings of the National Academy of Sciences
Published
2005-03-14
Volume
102
Issue
12
Pages
4548-4553
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1986111503
Cited by
289
References
31
Citations by year
2026: 11 · 2025: 14 · 2024: 7 · 2023: 15 · 2022: 13 · 2021: 13 · 2020: 11 · 2019: 19 · 2018: 19 · 2017: 26 · 2016: 9 · 2015: 15 · 2014: 26 · 2013: 8 · 2012: 15
FWCI
7.68
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Allergy and Infectious Diseases (R01AI043420, AI-43420)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
Keywords
Mycobacterium tuberculosis, antitubercular agents, aerobic respiratory chain, electron transport inhibition, drug resistance, low oxygen tension
MeSH terms
Animals, Antitubercular Agents, Electron Transport, Enzyme Inhibitors, Escherichia coli, Female, Genes, Bacterial, Mice, Inbred BALB C, Mycobacterium tuberculosis, Oxygen Consumption, Phenothiazines, Quinone Reductases, Recombinant Proteins, Tuberculosis, Pulmonary, Electron Transport Complex III, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs. https://app.cochat.ai/papers/10.1073/pnas.0500469102
The paper
Weinstein, E. A., Yano, T., Li, L.-S., Avarbock, D., Avarbock, A., Helm, D., McColm, A. A., Duncan, K., Lonsdale, J. T., & Rubin, H. (2005). Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0500469102

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.